Cresco Labs Inc. (CRLBF) Non-Current Deferred Tax Liability (2019 - 2026)

Cresco Labs (CRLBF) has reported Non-Current Deferred Tax Liability for 8 consecutive years, with $19.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Deferred Tax Liability fell 51.13% year-over-year to $19.0 million; the trailing twelve-month figure through Jun 2026 stood at $19.0 million (down 51.13% YoY), and the FY2025 full-year result was $33.6 million, down 13.69% from the prior year.
• Non-Current Deferred Tax Liability eased to $19.0 million in Q2 2026 per CRLBF's latest filing, from $33.8 million in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $84.2 million in Q1 2022 and bottomed at $19.0 million in Q2 2026.
• Historically, Non-Current Deferred Tax Liability has averaged $51.1 million across 5 years, with a median of $40.9 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Non-Current Deferred Tax Liability jumped 93.39% in 2022, then plunged 51.13% in 2026.
• Over 5 years, Non-Current Deferred Tax Liability stood at $75.1 million in 2022, then tumbled by 46.16% to $40.5 million in 2023, then dropped by 3.72% to $38.9 million in 2024, then fell by 13.69% to $33.6 million in 2025, then plunged by 43.57% to $19.0 million in 2026.
• According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $19.0 million, $33.8 million, and $33.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.